Skip to main content
Top
Published in:

Open Access 01-12-2024 | Multiple Sclerosis | Research

The impact of social and environmental factors on triggering multiple sclerosis onset, before and during the COVID-19 pandemic: a retrospective study from Iran

Authors: Naghmeh Abbasi Kasbi, Fereshteh Ghadiri, Abdorreza Naser Moghadasi, Faezeh Khodaie, Kosar Kohandel, Nasim Rezaeimanesh, Maryam Karaminia, Mohammad Ali Sahraian

Published in: BMC Neurology | Issue 1/2024

Login to get access

Abstract

Background

Multiple sclerosis (MS) is a chronic, inflammatory, and demyelinating disease of the central nervous system. The first presentation’s possible triggers are still controversial among scientists. The objective of this study is to investigate and compare the potential social, environmental, and physical factors that may have contributed to the onset of MS before and during the Coronavirus Disease 2019 (COVID-19) pandemic.

Methods

A questionnaire was designed in the MS research center of Sina Hospital and also distributed as an online Google Form on social media among Iranian MS patients. Demographic information, MS disease-related data, and possible patients reported MS triggers were recorded. They were containing stressful life events, COVID-19 and other infections, COVID-19 and other vaccines, pregnancy or labor, head trauma, surgery, and weight loss. Patients were divided into two groups regarding the time of MS diagnosis (before and during the COVID-19 pandemic).

Results

Of 920 participants, 670 (72.8%) were female, and the mean age ± SD was 35.63 ± 8.1. The majority of patients (69.2%) had non-progressive forms of MS, and only 7.6% needed assistance for ambulation. 69% of participants were diagnosed with MS before the onset of the COVID-19 pandemic. There was a statistically significant difference between the most common first MS symptom before and after the beginning of the pandemic (visual type (n: 317 (49.9%)) before and sensory type (n: 170 (59.6%)) after the COVID-19 pandemic). A stressful life event was the most common patient-reported trigger of MS first presentation in both groups. (56.1% before and 54% after the COVID-19 pandemic). Comparing two groups, economic problems (AOR: 1.81; 95% ACI: 1.23–2.65) and job losses (AOR: 2.89; 95% ACI: 1.37–6.08) were significantly more common triggers for the initial presentation of MS after the pandemic, while the stress of occupational or educational exams (AOR: 0.52; 95% ACI: 0.34–0.79) was more prevalent before the pandemic.

Conclusion

Patients believe that stressful life events are closely linked to triggering their first MS symptoms. Since the beginning of the COVID-19 pandemic, economic problems and job losses have increased; however, occupational or educational exams stress decreased. Caring for social stress by societies may affect MS development or delay MS onset.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kamińska J, Koper OM, Piechal K, Kemona H. Multiple sclerosis - etiology and diagnostic potential. Postepy Hig Med Dosw (Online). 2017;71(0):551–63.PubMed Kamińska J, Koper OM, Piechal K, Kemona H. Multiple sclerosis - etiology and diagnostic potential. Postepy Hig Med Dosw (Online). 2017;71(0):551–63.PubMed
3.
go back to reference Noonan CW, Kathman SJ, White MC. Prevalence estimates for MS in the United States and evidence of an increasing trend for women. Neurology. 2002;58(1):136–8.CrossRefPubMed Noonan CW, Kathman SJ, White MC. Prevalence estimates for MS in the United States and evidence of an increasing trend for women. Neurology. 2002;58(1):136–8.CrossRefPubMed
4.
go back to reference Giovannoni G. Targeting Epstein-Barr virus in multiple sclerosis: when and how? Current opinion in neurology. 2024;37(3):228–36. Giovannoni G. Targeting Epstein-Barr virus in multiple sclerosis: when and how? Current opinion in neurology. 2024;37(3):228–36.
5.
go back to reference Povolo CA, Reid JN, Shariff SZ, Welk B, Morrow SA. Concussion in adolescence and the risk of multiple sclerosis: a retrospective cohort study. Mult Scler. 2021;27(2):180–7.CrossRefPubMed Povolo CA, Reid JN, Shariff SZ, Welk B, Morrow SA. Concussion in adolescence and the risk of multiple sclerosis: a retrospective cohort study. Mult Scler. 2021;27(2):180–7.CrossRefPubMed
6.
go back to reference Varytė G, Zakarevičienė J, Ramašauskaitė D, Laužikienė D, Arlauskienė A. Pregnancy and Multiple Sclerosis: An Update on the Disease Modifying Treatment Strategy and a Review of Pregnancy’s Impact on Disease Activity. Med (Kaunas Lithuania). 2020;56(2). Varytė G, Zakarevičienė J, Ramašauskaitė D, Laužikienė D, Arlauskienė A. Pregnancy and Multiple Sclerosis: An Update on the Disease Modifying Treatment Strategy and a Review of Pregnancy’s Impact on Disease Activity. Med (Kaunas Lithuania). 2020;56(2).
7.
go back to reference Jiang J, Abduljabbar S, Zhang C, Osier N. The relationship between stress and disease onset and relapse in multiple sclerosis: a systematic review. Multiple Scler Relat Disorders. 2022;67:104142.CrossRef Jiang J, Abduljabbar S, Zhang C, Osier N. The relationship between stress and disease onset and relapse in multiple sclerosis: a systematic review. Multiple Scler Relat Disorders. 2022;67:104142.CrossRef
8.
go back to reference Abdollahpour I, Nedjat S, Mansournia MA, Eckert S, Weinstock-Guttman B. Stress-full life events and multiple sclerosis: a population-based incident case-control study. Multiple Scler Relat Disorders. 2018;26:168–72.CrossRef Abdollahpour I, Nedjat S, Mansournia MA, Eckert S, Weinstock-Guttman B. Stress-full life events and multiple sclerosis: a population-based incident case-control study. Multiple Scler Relat Disorders. 2018;26:168–72.CrossRef
9.
go back to reference AlZahrani AS, Alshamrani FJ, Al-Khamis FA, Al-Sulaiman AA, Al Ghamdi WS, Al Ghamdi OA, et al. Association of acute stress with multiple sclerosis onset and relapse in Saudi Arabia. Saudi Med J. 2019;40(4):372–8.CrossRefPubMedPubMedCentral AlZahrani AS, Alshamrani FJ, Al-Khamis FA, Al-Sulaiman AA, Al Ghamdi WS, Al Ghamdi OA, et al. Association of acute stress with multiple sclerosis onset and relapse in Saudi Arabia. Saudi Med J. 2019;40(4):372–8.CrossRefPubMedPubMedCentral
10.
go back to reference Hachim MY, Elemam NM, Maghazachi AA. The Beneficial and Debilitating effects of Environmental and Microbial toxins, drugs, Organic solvents and Heavy metals on the Onset and Progression of multiple sclerosis. Toxins (Basel). 2019;11(3). Hachim MY, Elemam NM, Maghazachi AA. The Beneficial and Debilitating effects of Environmental and Microbial toxins, drugs, Organic solvents and Heavy metals on the Onset and Progression of multiple sclerosis. Toxins (Basel). 2019;11(3).
11.
go back to reference Kaźmierski R, Wender M, Guzik P, Zielonka D. Association of influenza incidence with multiple sclerosis onset. Folia Neuropathol. 2004;42(1):19–23.PubMed Kaźmierski R, Wender M, Guzik P, Zielonka D. Association of influenza incidence with multiple sclerosis onset. Folia Neuropathol. 2004;42(1):19–23.PubMed
12.
go back to reference Brütting C, Stangl GI, Staege MS, Vitamin D. Epstein-Barr virus, and endogenous retroviruses in multiple sclerosis - facts and hypotheses. JIN. 2021;20(1):233–8.CrossRef Brütting C, Stangl GI, Staege MS, Vitamin D. Epstein-Barr virus, and endogenous retroviruses in multiple sclerosis - facts and hypotheses. JIN. 2021;20(1):233–8.CrossRef
13.
go back to reference Shiba N, Inaba Y, Motobayashi M, Nishioka M, Kawasaki Y, Noda S, et al. A Pediatric Case of relapsing-remitting multiple sclerosis onset following Varicella Zoster Ophthalmicus with Optic Neuritis. Case Rep Pediatr. 2018;2018:6931206.PubMedPubMedCentral Shiba N, Inaba Y, Motobayashi M, Nishioka M, Kawasaki Y, Noda S, et al. A Pediatric Case of relapsing-remitting multiple sclerosis onset following Varicella Zoster Ophthalmicus with Optic Neuritis. Case Rep Pediatr. 2018;2018:6931206.PubMedPubMedCentral
14.
go back to reference Lima M, Aloizou AM, Siokas V, Bakirtzis C, Liampas I, Tsouris Z, et al. Coronaviruses and their relationship with multiple sclerosis: is the prevalence of multiple sclerosis going to increase after the Covid-19 pandemia? Rev Neurosci. 2022;33(7):703–20.CrossRefPubMed Lima M, Aloizou AM, Siokas V, Bakirtzis C, Liampas I, Tsouris Z, et al. Coronaviruses and their relationship with multiple sclerosis: is the prevalence of multiple sclerosis going to increase after the Covid-19 pandemia? Rev Neurosci. 2022;33(7):703–20.CrossRefPubMed
15.
go back to reference Mares J, Hartung HP. Multiple sclerosis and COVID-19. Biomedical papers of the Medical Faculty of the University Palacky. Olomouc Czech Repub. 2020;164(3):217–25. Mares J, Hartung HP. Multiple sclerosis and COVID-19. Biomedical papers of the Medical Faculty of the University Palacky. Olomouc Czech Repub. 2020;164(3):217–25.
16.
go back to reference Bazylewicz M, Gudowska-Sawczuk M, Mroczko B, Kochanowicz J, Kułakowska A. COVID-19: the Course, Vaccination and Immune Response in people with multiple sclerosis: systematic review. Int J Mol Sci. 2023;24(11). Bazylewicz M, Gudowska-Sawczuk M, Mroczko B, Kochanowicz J, Kułakowska A. COVID-19: the Course, Vaccination and Immune Response in people with multiple sclerosis: systematic review. Int J Mol Sci. 2023;24(11).
17.
go back to reference Naser Moghadasi A. A 31-year-old female patient with concurrent clinical onset of multiple sclerosis and COVID-19: possible role of SARS-CoV-2 in the pathogenesis of multiple sclerosis. Autoimmun Rev. 2021;20(5):102803.CrossRefPubMedPubMedCentral Naser Moghadasi A. A 31-year-old female patient with concurrent clinical onset of multiple sclerosis and COVID-19: possible role of SARS-CoV-2 in the pathogenesis of multiple sclerosis. Autoimmun Rev. 2021;20(5):102803.CrossRefPubMedPubMedCentral
18.
go back to reference Ismail II, Salama S. A systematic review of cases of CNS demyelination following COVID-19 vaccination. J Neuroimmunol. 2022;362:577765.CrossRefPubMed Ismail II, Salama S. A systematic review of cases of CNS demyelination following COVID-19 vaccination. J Neuroimmunol. 2022;362:577765.CrossRefPubMed
19.
go back to reference Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162–73.CrossRefPubMed Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162–73.CrossRefPubMed
20.
go back to reference Beier M, D’Orio V, Spat J, Shuman M, Foley FW. Alcohol and substance use in multiple sclerosis. J Neurol Sci. 2014;338(1–2):122–7.CrossRefPubMed Beier M, D’Orio V, Spat J, Shuman M, Foley FW. Alcohol and substance use in multiple sclerosis. J Neurol Sci. 2014;338(1–2):122–7.CrossRefPubMed
21.
go back to reference Caslin B, Mohler K, Thiagarajan S, Melamed E. Alcohol as friend or foe in autoimmune diseases: a role for gut microbiome? Gut Microbes. 2021;13(1):1916278.CrossRefPubMedPubMedCentral Caslin B, Mohler K, Thiagarajan S, Melamed E. Alcohol as friend or foe in autoimmune diseases: a role for gut microbiome? Gut Microbes. 2021;13(1):1916278.CrossRefPubMedPubMedCentral
22.
go back to reference Holick MF. The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Reviews Endocr Metabolic Disorders. 2017;18(2):153–65.CrossRef Holick MF. The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Reviews Endocr Metabolic Disorders. 2017;18(2):153–65.CrossRef
23.
go back to reference Rosso M, Chitnis T. Association between cigarette smoking and multiple sclerosis: a review. JAMA Neurol. 2020;77(2):245–53.CrossRefPubMed Rosso M, Chitnis T. Association between cigarette smoking and multiple sclerosis: a review. JAMA Neurol. 2020;77(2):245–53.CrossRefPubMed
24.
go back to reference Shah A, Kumar D, Preet Singh G, Shukla P. Pattern of failure among HNSCC: an Institution-based study. Bengal J Cancer. 2021;1(2). Shah A, Kumar D, Preet Singh G, Shukla P. Pattern of failure among HNSCC: an Institution-based study. Bengal J Cancer. 2021;1(2).
25.
go back to reference Kohandel K, Abbasi N, Rezaeimanesh N, Moghadasi AN, Navardi S, Rezaei A, et al. The Association between Demographic and Clinical Characteristics with Tobacco Smoking, Alcohol Consumption, and drug abuse in Iranian patients with multiple sclerosis (MS). Multiple Scler Relat Disorders. 2023;80:105216.CrossRef Kohandel K, Abbasi N, Rezaeimanesh N, Moghadasi AN, Navardi S, Rezaei A, et al. The Association between Demographic and Clinical Characteristics with Tobacco Smoking, Alcohol Consumption, and drug abuse in Iranian patients with multiple sclerosis (MS). Multiple Scler Relat Disorders. 2023;80:105216.CrossRef
26.
go back to reference Djelilovic-Vranic J, Alajbegovic A, Tiric-Campara M, Nakicevic A, Osmanagic E, Salcic S, et al. Stress as provoking factor for the first and repeated multiple sclerosis seizures. Mater Sociomed. 2012;24(3):142–7.CrossRefPubMedPubMedCentral Djelilovic-Vranic J, Alajbegovic A, Tiric-Campara M, Nakicevic A, Osmanagic E, Salcic S, et al. Stress as provoking factor for the first and repeated multiple sclerosis seizures. Mater Sociomed. 2012;24(3):142–7.CrossRefPubMedPubMedCentral
27.
go back to reference Nicola M, Alsafi Z, Sohrabi C, Kerwan A, Al-Jabir A, Iosifidis C, et al. The socio-economic implications of the coronavirus pandemic (COVID-19): a review. Int J Surg. 2020;78:185–93.CrossRefPubMedPubMedCentral Nicola M, Alsafi Z, Sohrabi C, Kerwan A, Al-Jabir A, Iosifidis C, et al. The socio-economic implications of the coronavirus pandemic (COVID-19): a review. Int J Surg. 2020;78:185–93.CrossRefPubMedPubMedCentral
28.
29.
go back to reference Sharifi MH, Keshani P, Salehi A, Jaladat AM, Mirzaei Z, Nikseresht A. Association between multiple sclerosis and dietary patterns based on the traditional concept of food nature: a case-control study in Iran. BMC Neurol. 2021;21(1):453.CrossRefPubMedPubMedCentral Sharifi MH, Keshani P, Salehi A, Jaladat AM, Mirzaei Z, Nikseresht A. Association between multiple sclerosis and dietary patterns based on the traditional concept of food nature: a case-control study in Iran. BMC Neurol. 2021;21(1):453.CrossRefPubMedPubMedCentral
30.
go back to reference Moore L, Ghannam M, Manousakis G. A first presentation of multiple sclerosis with concurrent COVID-19 infection. eNeurologicalSci. 2021;22:100299.CrossRefPubMed Moore L, Ghannam M, Manousakis G. A first presentation of multiple sclerosis with concurrent COVID-19 infection. eNeurologicalSci. 2021;22:100299.CrossRefPubMed
31.
go back to reference Yavari F, Raji S, Moradi F, Saeidi M. Demyelinating changes alike to multiple sclerosis: a Case Report of Rare manifestations of COVID-19. Case Rep Neurol Med. 2020;2020:6682251.PubMedPubMedCentral Yavari F, Raji S, Moradi F, Saeidi M. Demyelinating changes alike to multiple sclerosis: a Case Report of Rare manifestations of COVID-19. Case Rep Neurol Med. 2020;2020:6682251.PubMedPubMedCentral
32.
go back to reference Palao M, Fernández-Díaz E, Gracia-Gil J, Romero-Sánchez CM, Díaz-Maroto I, Segura T. Multiple sclerosis following SARS-CoV-2 infection. Mult Scler Relat Disord. 2020;45:102377.CrossRefPubMedPubMedCentral Palao M, Fernández-Díaz E, Gracia-Gil J, Romero-Sánchez CM, Díaz-Maroto I, Segura T. Multiple sclerosis following SARS-CoV-2 infection. Mult Scler Relat Disord. 2020;45:102377.CrossRefPubMedPubMedCentral
33.
go back to reference Fragoso YD, Pacheco FA, Silveira GL, Oliveira RA, Carvalho VM, Martimbianco ALC. COVID-19 in a temporal relation to the onset of multiple sclerosis. Multiple Scler Relat Disorders. 2021;50:102863.CrossRef Fragoso YD, Pacheco FA, Silveira GL, Oliveira RA, Carvalho VM, Martimbianco ALC. COVID-19 in a temporal relation to the onset of multiple sclerosis. Multiple Scler Relat Disorders. 2021;50:102863.CrossRef
34.
go back to reference Witman Tsur S, Adrian Zaher E, Tsur M, Kania K, Kalinowska-Łyszczarz A. Current immunological and clinical perspective on vaccinations in multiple sclerosis patients: are they safe after all? Int J Mol Sci. 2021;22(8). Witman Tsur S, Adrian Zaher E, Tsur M, Kania K, Kalinowska-Łyszczarz A. Current immunological and clinical perspective on vaccinations in multiple sclerosis patients: are they safe after all? Int J Mol Sci. 2021;22(8).
35.
go back to reference Abbasi N, Ghadiri F, Moghadasi AN, Azimi A, Navardi S, Heidari H, et al. COVID-19 vaccine hesitancy in Iranian patients with multiple sclerosis. Multiple Scler Relat Disorders. 2022;60:103723.CrossRef Abbasi N, Ghadiri F, Moghadasi AN, Azimi A, Navardi S, Heidari H, et al. COVID-19 vaccine hesitancy in Iranian patients with multiple sclerosis. Multiple Scler Relat Disorders. 2022;60:103723.CrossRef
36.
go back to reference Ghajarzadeh M, Foroushani AR, Ghezelbash P, Ghoreishi A, Maghbooli M, Yousefi M, et al. Prevalence of multiple sclerosis (MS) in Zanjan Province of Iran. Int J Prev Med. 2020;11:116.CrossRefPubMedPubMedCentral Ghajarzadeh M, Foroushani AR, Ghezelbash P, Ghoreishi A, Maghbooli M, Yousefi M, et al. Prevalence of multiple sclerosis (MS) in Zanjan Province of Iran. Int J Prev Med. 2020;11:116.CrossRefPubMedPubMedCentral
37.
go back to reference Delavari F, Varzaneh FN, Rezaei N. Neurologic manifestations of COVID-19. Adv Exp Med Biol. 2021;1318:343–53.CrossRefPubMed Delavari F, Varzaneh FN, Rezaei N. Neurologic manifestations of COVID-19. Adv Exp Med Biol. 2021;1318:343–53.CrossRefPubMed
Metadata
Title
The impact of social and environmental factors on triggering multiple sclerosis onset, before and during the COVID-19 pandemic: a retrospective study from Iran
Authors
Naghmeh Abbasi Kasbi
Fereshteh Ghadiri
Abdorreza Naser Moghadasi
Faezeh Khodaie
Kosar Kohandel
Nasim Rezaeimanesh
Maryam Karaminia
Mohammad Ali Sahraian
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2024
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-024-03956-x